CN
News & Events

News & Events

Chipscreen Highlights: Stay Updated on Recent Hot Topics

Select year

2026 2025 2024 2023 2022 Earlier
shown/page
5
5 10 15 20

2024.06.08

Chipscreen Biosciences' Chidamide tablets designated as a breakthrough therapy for advanced colorectal cancer
Chipscreen Biosciences' Chidamide tablets designated as a breakthrough therapy for advanced colorectal cancer

Full text

2024.04.30

National Medical Products Administration (NMPA) Approves Chipscreen Bioscience’s Chidamide (Epidaza) combined with R-CHOP for the treatment of diffuse large B-cell lymphoma
National Medical Products Administration (NMPA) Approves Chipscreen Bioscience’s Chidamide (Epidaza) combined with R-CHOP for the treatment of diffuse large B-cell lymphoma

Full text

2024.04.25

“Chinese Researchers + Innovative Drugs” Shine on the Global Stage | Chidamide Clinical Studies Selected for 2024 ASCO LBA and Multiple Presentations
“Chinese Researchers + Innovative Drugs” Shine on the Global Stage | Chidamide Clinical Studies Selected for 2024 ASCO LBA and Multiple Presentations

Full text

2024.03.18

Wang Cheng, Secretary of the Party Committee and Chairman of Sichuan Energy Investment, and his team visited Chipscreen Biosciences for inspection and survey
Wang Cheng, Secretary of the Party Committee and Chairman of Sichuan Energy Investment, and his team visited Chipscreen Biosciences for inspection and survey

Full text

2024.03.18

Positive results from Phase II clinical trial (CGZ203 study) of Chiglitazar monotherapy for non-alcoholic steatohepatitis
Positive results from Phase II clinical trial (CGZ203 study) of Chiglitazar monotherapy for non-alcoholic steatohepatitis

Full text
Media contact

Media contact

  • Media contact

    （+86）0755-36993500

  • Media contact

    pr@juliucq.com

<p id="z0vxc1ra"></p>